Skip to main content Skip to main navigation menu Skip to site footer

Variations of dengue shock syndrome cases and their management: report of three cases


Background: Dengue hemorrhagic fever (DHF) occurs due to plasma leakage due to increased vascular permeability, which is also supported by an active complement system, which makes DHF fall into complications such as shock or dengue shock syndrome (DSS). The comprehensive management of DSS could prevent morbidity and mortality in patients. We aimed to report three variations of dengue shock syndrome cases and their management.

Case presentation: Three cases of DSS from our hospital. Two case reports with clinical dengue fever patients with shock and one case report with clinical dengue patients with shock and complications of acute liver failure. The first case was a 24 years olds male patient with classic signs of dengue fever plus spontaneous bleeding in the form of nosebleeds accompanied by hemodynamic disturbances. Laboratory examination revealed severe thrombocytopenia. In the second case, a male patient with dengue shock syndrome accompanied acute liver failure. The patient complains of heartburn and nausea accompanied by tea-like urine. Dengue patients with abdominal pain typical of liver disorders, nausea, vomiting and anorexia, and hepatomegaly with or without jaundice are typical of liver disorders. The third case, a male patient with dengue shock syndrome, accompanied the suspicion of ascites. The main treatment is the administration of isotonic crystalloid fluids according to body weight. While in cases of acute liver failure, NAC can be given.

Conclusion: We found three cases of DSS with some complications. It is important to know the right treatment immediately so that complications do not occur.


  1. Centers for Diseases Control and Prevention (CDC). Dengue and Dengue Haemorhagic Fever. Comprehensive Guideline For Prevention and Control. 2011.
  2. Koibur JG, Satyarsa AB, Gustawan IW, Putra IG, Utama IM. Lingkungan Tempat Tinggal Sebagai Faktor Resiko Infeksi Virus Dengue Pada Anak-Anak. Indonesian Journal for Health Sciences. 2021;5(1):1-7.
  3. KEMENKES RI. Pencegahan dan pengendalian Demam Berdarah di Indonesia. Kementrian Kesehatan Republik Indonesia. 2017
  4. Mustafa MS, Rasotgi V, Jain S, Gupta V (2015) Discovery of ffth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control. Med J Armed Forces India 71(1):67–70
  5. Wang W, Nayim A, Chang MR, Assavalapsakul W, Lu P, Chen Y, et al. Dengue hemorrhagic fever e A systemic literature review of current perspectives on pathogenesis , prevention and control. J Microbiol Immunol Infect [Internet]. 2020;53(6):963–78. Available from:
  6. WHO, & Regional Office for South-East Asia. (2011). Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. In SEARO Technical.
  7. Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of dengue virus infection. Current microbiology. 2021 Jan;78(1):17-32.
  8. Lewis J, Mitra A, Chang M. Acute liver failure in a patient with dengue shock syndrome. ACG Case Reports Journal. 2020 Apr;7(4).
  9. Suganthan N, Sakthilingham G, Kumanan T. Dengue fever complicated with acute liver failure: A case report of expanded dengue syndrome and literature review. SAGE Open Medical Case Reports. 2020 Mar;8:2050313X20913428.
  10. Lin C-F, Wan S-W, Chen M-C, Lin S-C, Cheng C-C, Chiu S-C et al (2008) Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab Invest 88(10):1079–1089
  11. Rahmawati A, Perwitasari DA, Kurniawan NU. Efektivitas Pemberian Terapi Cairan Inisial Dibandingkan Terapi Cairan Standar WHO terhadap Lama Perawatan pada Pasien Demam Berdarah di Bangsal Anak Rumah Sakit PKU Muhammadiyah Bantul. Indonesian Journal of Clinical Pharmacy. 2019 Jun 28;8(2):91-8.
  12. Setiawan B, Chen K, Pohan HT. Diagnosis dan terapi cairan pada demam berdarah dengue. Jurnal Medicinus. 2009;22(1).
  13. Setiati TE. Use of HES 6% in children with dengue shock syndrome. Crit Care and Shock suppl 2000;34
  14. Wills AB, Dung NM, Loan HT et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005;353(9):877-99
  15. Suratni, & Anggriani, Yusi & Banun, Agusdini. (2018). Analisis Efektivitas Biaya Kristaloid dan Kombinasi Kristaloid-Koloid pada Penyakit Demam Berdarah Tanpa Syok di RSU Bhakti Asih Tangerang Cost Effectiveness Analysis of Crystalloid and Crystaloid-Colloid Combination on Dengue Fever Without Shock in Bhakti Asih General Hospital Tangerang. 10.13140/RG.2.2.19631.38564.
  16. Tafere GG, Wondafrash DZ, Demoz FB. Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure. Hepatic Medicine: Evidence and Research. 2020;12:173.
  17. Habaragamuwa BW, Dissanayaka P. N-acetylcystein in dengue associated severe hepatitis. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine. 2014 Mar;18(3):181.
  18. Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017 Nov 17;358(6365):929-32.

How to Cite

Wirajaya, G. B. M., Sutanegara, A. A. P. P. D. ., & Lestari, D. N. D. . (2022). Variations of dengue shock syndrome cases and their management: report of three cases. Intisari Sains Medis, 13(3), 625–631.




Search Panel

Gede Bagus Mahendra Wirajaya
Google Scholar
ISM Journal

Ayu Agung Pradnya Paramitha Dwi Sutanegara
Google Scholar
ISM Journal

Desak Nyoman Desy Lestari
Google Scholar
ISM Journal